EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Elucidation of DPP‐4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss–Newton method

Ryo Nakamura, Takashi Yoshikado iD, Yasunori Aoki iD, Yuichi Sugiyama iD, Koji Chiba iD

Clinical and Translational Science · 2024

DOI: 10.1111/cts.70047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, 2024. Verfasst von Ryo Nakamura und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmacology, Yokohama University of Pharmacy, Yokohama-shi, Kanagawa, Japan. Hauptthemen laut MEDLINE: Linagliptin, Dipeptidyl Peptidase 4, Dipeptidyl-Peptidase IV Inhibitors, Models, Biological. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science, and Technology in Japan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The dipeptidyl peptidase‐4 (DPP‐4) inhibitor linagliptin (LNG) exhibits target‐mediated drug disposition (TMDD) in clinical settings, characterized by saturable binding to plasma soluble DPP‐4 (sDPP‐4) and tissue transmembrane DPP‐4 (tDPP‐4). Previous studies have indicated that saturable renal reabsorption of LNG contributes to its nonlinear urinary excretion observed in humans and wild‐type mice, but not in Dpp‐4 knockout mice. To elucidate the mechanisms underlying these complex phenomena, including DPP‐4‐related renal reabsorption of LNG, we employed physiologically‐based pharmacokinetic (PBPK) modeling combined with a cluster Gauss–Newton method (CGNM). The CGNM facilitated the exploration of parameters in rat and human PBPK models for LNG and the determination of parameter identifiability. Through PBPK–CGNM analysis using reported autoradiography data ([ 14 C]‐LNG) in wild‐type and Dpp‐4‐deficient rats, DPP‐4‐specific distributions of LNG in various tissues were clearly differentiated from nonspecific parts. By fitting to human plasma concentrations and urinary and fecal excretions of LNG after intravenous and oral administrations, multiple unknown PBPK parameters were simultaneously estimated by the CGNM. Notably, the amount of tDPP‐4 and the reabsorption clearance for LNG–DPP‐4 complexes were identifiable, indicating their critical role in explaining the complex nonlinear pharmacokinetics of LNG. Compared with previous PBPK analyses, the CGNM allowed us to incorporate greater model complexity (e.g., consideration of tDPP‐4 expressions and in vitro binding kinetics), ultimately resulting in a more accurate reproduction of LNG's TMDD. In conclusion, by considering LNG as a high‐affinity probe for DPP‐4, comprehensive PBPK–CGNM analyses suggested a dynamic whole‐body distribution of DPP‐4, including its involvement in the renal reabsorption of LNG.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LinagliptinDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsModels, BiologicalRenal ReabsorptionAnimalsHumansRatsTissue DistributionMaleKidneyMice, KnockoutMice

Substanzen

LinagliptinDipeptidyl Peptidase 4Dipeptidyl-Peptidase IV InhibitorsDPP4 protein, humanDPP4 protein, rat

Autor:innen und Institutionen

  • Laboratory of Clinical Pharmacology, Yokohama University of Pharmacy, Yokohama-shi, Kanagawa, Japan.
  • Datascience Division, A2 Healthcare Corporation, Tokyo, Japan.
  • Laboratory of Quantitative System Pharmacokinetics/Pharmacodynamics, Josai International University, Tokyo, Japan.
  • iHuman Institute, ShanghaiTech University, Shanghai, China.

ORCID-Profile: Takashi Yoshikado, Yasunori Aoki, Yuichi Sugiyama, Koji Chiba

Förderung

  • Ministry of Education, Culture, Sports, Science, and Technology in Japan

Zitieren

APA

Nakamura, R., Yoshikado, T., Aoki, Y., Sugiyama, Y., & Chiba, K. (2024). Elucidation of DPP‐4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss–Newton method. Clinical and Translational Science. https://doi.org/10.1111/cts.70047

Vancouver

Nakamura R, Yoshikado T, Aoki Y, Sugiyama Y, Chiba K. Elucidation of DPP‐4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss–Newton method. Clinical and Translational Science. 2024. doi:10.1111/cts.70047

BibTeX
@article{Nakamura2024,
  author = {Nakamura, Ryo and Yoshikado, Takashi and Aoki, Yasunori and Sugiyama, Yuichi and Chiba, Koji},
  title = {Elucidation of DPP‐4 involvement in systemic distribution and renal reabsorption of linagliptin by PBPK modeling with a cluster Gauss–Newton method},
  journal = {Clinical and Translational Science},
  year = {2024},
  doi = {10.1111/cts.70047}
}
Kostenlos starten →